Breaking
Medicus Pharma Ltd. to Present at Biotech Showcase 2026, Advancing SkinJect ProgramEli Lilly's Legal Victory Over Noom's GLP-1 ClaimsBBSW AI Solution Event: Daily Roundup
Friday, July 10, 2026
🇺🇸 FDA

mosunetuzumab News

🇺🇸 FDA ← All news

FDA mosunetuzumab coverage for business development, investment, and market access teams

High impact AnalysisMay 1, 2026

Bispecific Antibodies in Hematological Malignancies: Teclistamab, Mosunetuzumab & Epcoritamab FDA Review

FDA · hematological malignancies · 8 min

Dr. Grace Tan
High impact AnalysisApr 28, 2026

Bispecific Antibodies in Hematological Malignancies: Teclistamab & Market Trends 2025

FDA · hematological malignancies · 5 min

Dr. Mei Lin
High impact AnalysisApr 27, 2026

Bispecific Antibody Therapies in B-Cell Lymphomas: FDA Approvals & Market Outlook

FDA · oncology · 10 min

Dr. Sarah Mitchell

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.